Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISDIPLAM vs RITALIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISDIPLAM vs RITALIN: Safety Overview

Metric RISDIPLAM RITALIN
Total FAERS Reports 3,619 123
Deaths Reported 336 7
Death Rate 9.3% 5.7%
Hospitalizations 719 23
Average Patient Age 21.8 yrs 27.5 yrs
% Female Patients 55.2% N/A
FDA Approval Date Aug 7, 2020 N/A
Manufacturer Genentech, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A